Sidoti Expects Increased Earnings for USANA Health Sciences

USANA Health Sciences, Inc. (NYSE:USNA) – Research analysts at Sidoti raised their Q1 2026 EPS estimates for shares of USANA Health Sciences in a research report issued to clients and investors on Thursday, February 19th. Sidoti analyst A. Lebiedzinski now expects that the company will earn $0.44 per share for the quarter, up from their previous estimate of $0.40. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. Sidoti also issued estimates for USANA Health Sciences’ Q2 2026 earnings at $0.45 EPS and Q3 2026 earnings at $0.45 EPS.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings data on Tuesday, February 17th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.19. The business had revenue of $226.20 million during the quarter, compared to the consensus estimate of $225.96 million. USANA Health Sciences had a net margin of 1.16% and a return on equity of 6.75%.

Other analysts also recently issued reports about the company. Weiss Ratings reiterated a “sell (d)” rating on shares of USANA Health Sciences in a research report on Monday, December 29th. Zacks Research upgraded shares of USANA Health Sciences from a “strong sell” rating to a “hold” rating in a report on Monday, February 16th. Two analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Reduce” and a consensus price target of $36.00.

USANA Health Sciences Stock Up 5.5%

USNA opened at $21.69 on Friday. The business has a fifty day moving average of $20.71 and a 200 day moving average of $23.53. The stock has a market cap of $396.46 million, a P/E ratio of 39.43, a PEG ratio of 0.81 and a beta of 0.67. USANA Health Sciences has a 52-week low of $18.48 and a 52-week high of $38.32.

Institutional Trading of USANA Health Sciences

A number of hedge funds have recently added to or reduced their stakes in the business. State of Tennessee Department of Treasury increased its position in USANA Health Sciences by 307.8% during the 4th quarter. State of Tennessee Department of Treasury now owns 29,290 shares of the company’s stock valued at $636,000 after purchasing an additional 22,108 shares during the period. Empowered Funds LLC increased its holdings in USANA Health Sciences by 10.6% during the fourth quarter. Empowered Funds LLC now owns 60,437 shares of the company’s stock valued at $1,186,000 after buying an additional 5,782 shares during the period. Tudor Investment Corp ET AL increased its holdings in USANA Health Sciences by 354.8% during the fourth quarter. Tudor Investment Corp ET AL now owns 109,686 shares of the company’s stock valued at $2,153,000 after buying an additional 85,570 shares during the period. Numerai GP LLC bought a new position in USANA Health Sciences in the fourth quarter worth approximately $1,027,000. Finally, Millennium Management LLC lifted its holdings in USANA Health Sciences by 715.7% during the fourth quarter. Millennium Management LLC now owns 285,416 shares of the company’s stock worth $5,603,000 after buying an additional 250,424 shares during the period. 54.25% of the stock is owned by hedge funds and other institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.